Request a Quote

Back to Pharmacology and Toxicology Assessment top page

Induction:

On study day 0, mice are sensitized with aliquots of 150 µL of a 5% oxazolone solution epicutaneously on their shaved abdomens. On day 7, the right ear of each mouse is challenged with 3% oxazolone solution (10 µL on the front and 10 µL on the back). Left ears are painted on both sides with an ethanol/acetone mixture.

Disease Parameters/Progression:

Mice develop swelling within 24 to 48 hours of antigen challenge.

Dosing Paradigms:

  • Treatment is administered 15 minutes to 1 hour prior to antigen challenge
  • Route of administration: SC, PO, IP, IV, topical

Clinical Assessment:

Body weights are taken on study days 0, 7, and 8 (prior to termination). Ear caliper measurements are taken on days 7 (baseline) and 8 using a Digitrix II micrometer (Fowler & NSK). On day 8 (24 hours post-antigen challenge), animals are necropsied. Measurement of the DTH reaction can be done grossly by comparing the ear core weight difference between normal versus antigen-injected ears (weight is proportional to edema). A 7-mm disc is collected by cork borer (Fisher Scientific) from the pinna of each ear and weighed.

Histopathological Assessment:

Tissues are examined microscopically by a board certified veterinary pathologist (Dr. Alison Bendele) and scored according to these methods.

Sample Data (Click on image to enlarge):

For more information about Oxazolone Induced Ear Delayed Type Hypersensitivity (Mouse) contact us here.

Notes:

Chemokines such as IL-8, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1a (MIP-1a), and macrophage migration inhibitory factor (MIF) have been found to be involved in the recruitment of leukocytes to the DTH reaction site. Cytokine inhibitors, such as anti-IL-16, have been shown to minimize the DTH response. Other compounds that effectively inhibit the DTH reaction are dexamethasone (a potent steroid that induces lympholysis) and cyclosporine-A (CsA), which inhibit the action and growth of T-lymphocytes.

Optional Endpoint

  • PK/PD blood collections
  • Cytokine/chemokine analysis via Luminex(R)
  • Other sandwich ELISAs
  • CBC/clinical chemistry analysis
  • Soft tissue collection
  • Histopathologic analysis
  • Immunohistochemistry analysis

References

  1. Yoshimoto T, Wang CR, Yoneto T, et al. Role of IL-16 in delayed-type hypersensitivity reaction. Blood. 2000;95(9):2869–2874.
  2. Owen J, Punt, J, Stranford S. Kuby Immunology. 7th ed. New York: WH Freeman & Company; 2013. Chapter 15, Inflammation: Allergy and Hypersensitivities.

Related Pages

General Inflammation

Back to Pharmacology and Toxicology Assessment top page